Although reported results vary, it is generally assumed that serum levels of proinflammatory cytokines, such as TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17A, IL-18 and IL-22, are elevated in patients with psoriasis and correlate with disease severity (40–43). This evidence concerns the gene IL17A and psoriasis.